Announcements Trials
Browse Landscape

Phase

Phase NA 3Phase 2 3

Status

Recruiting 2Terminated 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Other hematologic neoplasm 4Lymphoid 3Gastrointestinal 3Breast 2Myeloid 1Head & Neck 1

Conditions

Pancreatic Neoplasms 1Neoadjuvant Therapy in Rectal Cancer, Radiotherapy, FOLFOX 1Cholangiocarcinoma 1

Interventions

Oxaliplatin 780Fluorouracil 638Capecitabine 575Gemcitabine 478Leucovorin 459Bevacizumab 445Irinotecan 444Cisplatin 338Radiotherapy 283Cetuximab 252Paclitaxel 180S 1 (combination) 176pembrolizumab 173Docetaxel 156Drug Therapy 147Nivolumab 146sintilimab 143tislelizumab 131apatinib 131130-nm albumin-bound paclitaxel 128Folfox protocol 121durvalumab 119Albumin-Bound Paclitaxel 117camrelizumab 107lenvatinib 106Panitumumab 106regorafenib 102Surgical Procedures, Operative 102Sorafenib 99Radiation 88

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 2 × Clinical Protocols × Gastrointestinal × Clear all
NCT05557578 2025-02-11

GOT

Zhejiang Cancer Hospital

Phase 2 Recruiting
20 enrolled
Gastrointestinal

Cholangiocarcinoma

NCT03714555 2023-10-18

Disulfiram-Copper Gluconate in Met Pancreas Cancer w Rising CA19-9 on Abraxane-Gemzar, FOLFIRINOX or Gemcitabine

HonorHealth Research Institute

Phase 2 Terminated
1 enrolled 7 charts
Gastrointestinal

Pancreatic Neoplasms

NCT05378919 2022-05-18

RECTUM2015

Lithuanian University of Health Sciences

Phase 2 Recruiting
250 enrolled
Gastrointestinal

Neoadjuvant Therapy in Rectal Cancer, Radiotherapy, FOLFOX

Data powered by HemOnc (CC BY 4.0) Colophon âš¡